Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
DayTwo, an Israeli company that analyzes gut microbiomes to assist with nutrition and glycemic control, has raised $31 million in Series B financing. Ofek Ventures and aMoon led the round, with additional support coming from prior backers Seventure Partners and Johnson & Johnson.
With this, the company brings its total backing to $48 million.
WHAT THEY DO
DayTwo’s platform asks patients to...
